| Literature DB >> 32580030 |
Jiming Chen1, Xuefeng Fei1, Jianli Wang2, Zhijian Cai3.
Abstract
In recent decades, extracellular vesicles (EVs) have been proven to establish an important bridge of communication between cells or cells and their microenvironment. It is well known that EVs play crucial roles in many human diseases, especially in tumors. Tumor-derived EVs (TEVs) are not only involved in epithelial-mesenchymal transition and extracellular matrix remodeling to promote the invasion and metastasis, but also contribute to the suppression of antitumor immune responses by carrying different inhibitory molecules. In this review, we mainly discuss the effects of TEVs on the remodeling of tumor microenvironment through immune and non-immune associated mechanisms. We summarize the latest studies about utilizing EVs in clinical diagnosis and therapeutic drug delivery as well. In addition, the perspective of tumor therapy by targeting EVs is discussed in this review.Entities:
Keywords: Immunosuppressive molecules; Tumor microenvironment; Tumor therapy; Tumor-derived EVs
Mesh:
Substances:
Year: 2020 PMID: 32580030 DOI: 10.1016/j.phrs.2020.105041
Source DB: PubMed Journal: Pharmacol Res ISSN: 1043-6618 Impact factor: 7.658